Hillhouse, a global investment firm with deep experience in partnering with and supporting healthcare businesses, agreed to acquire George Clinical, a global clinical research organization. Financial terms were not disclosed. "Our acquisition by Hillhouse presents an immense opportunity for George Clinical to achieve even greater success in the next phase of our development. There is a good cultural and strategic fit with the team at Hillhouse and much synergy to be had with healthcare being a key sector of their portfolio. The path ahead is very exciting for our company, our staff and our clients as we will now have a bigger platform to continue our important mission to improve the health of millions of people worldwide and doing so with much more vigor in our new ownership structure," James Cheong, CEO.